HSD17B4 and prostate cancer: In breast and prostate cancers, CREBBP and SIRT3 regulate HSD17B4 acetylation at K669, which facilitates HSPA8-mediated CMA degradation, reducing HSD17B4 accumulation and suppressing migration and invasion [68, 69].